ANGO · Stephen Trowbridge, an officer of AngioDynamics, filed a Form 144…

Stephen Trowbridge, an officer of AngioDynamics, filed a Form 144 notice of intent to sell 23,615 shares of common stock, with an approximate market value of $289,722 based on the filing date. The shares were acquired through restricted stock vesting and employee stock purchase plan purchases over a multi-year period. The proposed sale represents a modest portion of the officer's total holdings and is routine in nature.

• Officer Stephen Trowbridge filed Form 144 to sell 23,615 shares of AngioDynamics common stock.
• Estimated sale value is approximately $289,722 based on the filing date.
• Shares were acquired via restricted stock vesting (08/03/2015 through 07/21/2025) and Employee Stock Purchase Plan (08/31/2015 through 08/31/2025).
• The sale is proposed to occur on or after 10/29/2026 on the Nasdaq exchange.